<?xml version="1.0" encoding="UTF-8"?><ns2:project xmlns:ns1="http://gtr.rcuk.ac.uk/gtr/api" xmlns:ns2="http://gtr.rcuk.ac.uk/gtr/api/project" xmlns:ns3="http://gtr.rcuk.ac.uk/gtr/api/fund" xmlns:ns4="http://gtr.rcuk.ac.uk/gtr/api/person" xmlns:ns5="http://gtr.rcuk.ac.uk/gtr/api/project/outcome" xmlns:ns6="http://gtr.rcuk.ac.uk/gtr/api/organisation" ns1:created="2026-06-22T07:57:45Z" ns1:href="http://gtr.ukri.org/gtr/api/projects/73764BA3-076E-4BDE-8220-33A268110DF1" ns1:id="73764BA3-076E-4BDE-8220-33A268110DF1"><ns1:links><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/persons/9C5931D2-58FF-4B3A-A79F-CC40185EE039" ns1:rel="PM_PER"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/0976B30F-EBB5-4736-9E80-97CE73D3E140" ns1:rel="LEAD_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/0976B30F-EBB5-4736-9E80-97CE73D3E140" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:end="2021-04-29T23:00:00Z" ns1:href="http://gtr.ukri.org/gtr/api/funds/A7FBB9ED-7267-43B4-BC11-EC2536EA1625" ns1:rel="FUND" ns1:start="2020-11-01T00:00:00Z"/></ns1:links><ns2:identifiers><ns2:identifier ns2:type="RCUK">84374</ns2:identifier></ns2:identifiers><ns2:title>RUBIVet: Rapid Urine based Bacteria Identification for Veterinary Applications</ns2:title><ns2:status>Closed</ns2:status><ns2:grantCategory>Collaborative R&amp;D</ns2:grantCategory><ns2:leadFunder>Innovate UK</ns2:leadFunder><ns2:abstractText>According to a recent survey of 532 veterinary surgeries by the Royal College of Veterinary Surgeons, 99% had noticeable reductions in weekly turnover, with 66% reporting reductions of 51% or more, as a result of social distancing measures implemented during the covid-19 pandemic. 451 of the 532 veterinary surgeries also reported that they had now moved to remote consultations which included new and repeat prescribing. 2-day laboratory testing has been the main stay for diagnosis of bacterial infections for nearly a century and is inherently sub-optimal for remote consultations. Our motivation is to challenge this distinct lack of innovation in this market and address the growing frustration amongst modern veterinarian with a simple, all-in-one solution to urine testing in animals.

In this project, we will be working closely with veterinary market leaders Anvajo GmBH, to deliver a rapid bacterial identification platform on Anvajo's pre-existing fluidlab R-300 device. This would maintain the same quality of results expected from a full laboratory analysis at a fraction of time, cost and inconvenience of the gold standard.</ns2:abstractText></ns2:project>